Recent and archived press releases with clinical and research news
Vanderbilt University Medical Center to be an early adopter as a hospital system integrating the Tennessee Advanced Communications Network into its existing network of emergency providers for redundancy communications in the event of a disaster.
A recent Vanderbilt poll found parents across the state reporting their children’s health care providers as the most trusted source for information about vaccines.
A Vanderbilt study found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic.
Vanderbilt’s Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.
Vanderbilt’s Stacie Dusetzina, PhD, and several colleagues were able to reflect recently on the South Lawn of the White House about how their contributions through research and data informed the provisions in the Inflation Reduction Act that will save older Americans on Medicare tens of thousands of dollars in out-of-pocket costs each year.
Accessibility Tools